Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CHUGAI-PHARMACEUTICAL-CO--6491165/news/Chugai-Pharmaceutical-Satralizumab-von-Chugai-erhalt-von-FDA-den-Status-Breakthrough-Therapy--27776791/?utm_source=whatsapp&utm_medium=social&utm_campaign=share